FDA Clarifies ‘Outsourcing Facility,’ Requirements for 503A Compounders
The FDA issued a final guidance clarifying the term “outsourcing facility” and detailing requirements for compounders operating under 503A that are next to an outsourcing facility.
Source: International Pharmaceutical Regulatory Monitor